TKA HRQoL: Progression of Health Related Quality of Life of Patients Waiting for Total Knee Arthroplasty

Sponsor
Dr. Ho Ki Wai (Other)
Overall Status
Completed
CT.gov ID
NCT03492320
Collaborator
(none)
127
45

Study Details

Study Description

Brief Summary

To evaluate the progression on patients suffering from end stage OA whilst being on the waiting list for TKR

Detailed Description

Total Knee Arthroplasty (TKA) remains the surgical gold standard treatment for patients suffering from end stage osteoarthritis (OA) of the knee. However, due to the high demand and scarce medical resources, the waiting time for surgery is astoundingly lengthy. Controversies are shown on numerous studies on whether physical functionality and mental status decline or remain stable over the waiting period. This study aims to evaluate the progression on patients suffering from end stage OA whilst being on the waiting list for TKR.

Study Design

Study Type:
Observational
Actual Enrollment :
127 participants
Observational Model:
Case-Only
Time Perspective:
Prospective
Official Title:
Progression of Health Related Quality of Life of Patients Waiting for Total Knee Arthroplasty
Actual Study Start Date :
Mar 1, 2013
Actual Primary Completion Date :
Dec 1, 2016
Actual Study Completion Date :
Dec 1, 2016

Outcome Measures

Primary Outcome Measures

  1. Western Ontario and McMaster University Osteoarthritis Index (WOMAC) [From March 2013 to December 2016]

    Questionnaire

  2. Self-Rated Questionnaire SF36 [From March 2013 to December 2016]

    Questionnaire

  3. Health Related Quality of Life (HRQoL) 15D [From March 2013 to December 2016]

    Questionnaire

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. diagnosed with symptomatic osteoarthritis

  2. Enlisted on the TKA surgical waiting list

  3. Ethnic Chinese

  4. Fluent in Cantonese

Exclusion Criteria:
  1. Evidence of cognitive dysfunction like dementia

  2. Surgery scheduled within 30 days

  3. Severe co-morbidity preluding participation

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Dr. Ho Ki Wai

Investigators

  • Principal Investigator: Ki Wai Ki Wai, Dr., Chinese University of Hong Kong

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Dr. Ho Ki Wai, Assistant Professor, Department of Orthopaedics & Traumatology; Director of MSc/PgD Programme in Musculoskeletal Medicine & Rehabilitation, Chinese University of Hong Kong
ClinicalTrials.gov Identifier:
NCT03492320
Other Study ID Numbers:
  • CUHK_2013.381
  • CREC Ref. No.
First Posted:
Apr 10, 2018
Last Update Posted:
Apr 10, 2018
Last Verified:
Apr 1, 2018
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Dr. Ho Ki Wai, Assistant Professor, Department of Orthopaedics & Traumatology; Director of MSc/PgD Programme in Musculoskeletal Medicine & Rehabilitation, Chinese University of Hong Kong
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 10, 2018